Skip to content
Search

Latest Stories

70 per cent of community pharmacies still waiting for government nod to start Covid booster jab

Nearly 70 per cent of community pharmacies in England that offered to participate in the Covid-19 booster programme are still waiting for approval or have been refused, ministers admitted on Monday (December 13).

The Liberal Democrats’ health spokesperson, Daisy Cooper, exposed the low approval rate and long delays through a written parliamentary question to the health secretary as to "how many community pharmacies were providing Covid-19 vaccinations as of 3 December 2021."


Maggie Throup MP New pharmacy minister Maggie Throup MP. Image courtesy: maggiethroup.com

In response vaccines minister Maggie Throup said: “As of the end of September 2021, 4,733 contractors submitted 5,376 expressions of interest to take part in the booster vaccination programme, with 1,454 accepted.”

The figures show an approval rate of 30.7 per cent.

She added: “As of 3 December 2021, 1,336 community pharmacy vaccination sites were actively providing the service.”

Some applications were decided by NHS England rather than the Department of Health and Social Care (DHSC).

Acknowledging long wait for giving a green signal to community pharmacies, Throup said: “Since 1 August, the shortest period from receipt of application to a pharmacy providing the Covid-19 vaccination service was 14 days, the longest was 78 days, with an average of 44 days.”

Sector reacts

Reacting to the data released by the minister, many from the sector have called on the government to increase the rate of approval for pharmacies by being less rigid in its requirements.

Alastair Buxton, director of NHS Services at Pharmaceutical Services Negotiating Committee (PSNC), said: “In community pharmacies we have a network of thousands of healthcare locations on the high street, many of whom are ready, willing and able to offer Covid vaccinations."

He added that many pharmacies are capable and willing to “support the NHS in delivering the ambitious booster campaign.”

“Pharmacy owners are at a loss to understand why nearly 4,000 sites which they felt could offer Covid vaccinations are not now being used to do so – this could help meet the prime minister’s targets, ease pressure on General Practice, and help improve accessibility for the public.

“We urge the NHS to revisit its policy on pharmacy vaccination sites and allow more pharmacies to play their part in this ongoing national health emergency.”

Insisting on the potential central role that community pharmacies could play in vaccination drive, Nick Kaye, vice chair of the National Pharmacy Association (NPA) said: “Thousands more pharmacies have offered to vaccinate and it’s scandalous that so many have been turned down.

“The NHS should be aiming to commission maximum provision, as this is a moment of national emergency.

“The queues outside current sites tell their own story.

“All existing pharmacy applications to become vaccine centres should be reconsidered immediately.  Even if it’s too late for most to be brought on line for the current burst, let’s get the sites approved now so that they can be stood up swiftly whenever the need arises.”

THORRUN GOVIND Thorrun Govind, chair of RPS in England

Thorrun Govind, Royal Pharmaceutical Society chair in England, told The Guardian: “On 13 December just 1,500 community pharmacies delivered 44 per cent of all the Covid booster jabs in England – 185,000 out of a total of 418,000 booster jabs – which is an extraordinary feat from an already exhausted workforce.

“The workforce is under enormous pressure and is delivering boosters at an incredible rate, but must not be shackled in the attempt by unnecessary officialdom.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less